CDT
HEALTHCARECDT Equity Inc
Live · NASDAQ · May 9, Close
What's Moving CDT Today?
No stock-specific AI insight has been generated for CDT yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$2.26
Fundamentals
Trading
CDT News
21 articles- CDT Notes Sarborg Filing of Substance of Matter Patent in Cystic Fibrosis MarketYahoo Finance·May 7, 2026
- CDT Advances AZD5904 into Global Patent Phase and Initiates Partnering DiscussionsYahoo Finance·May 6, 2026
- CDT Expands Multi-Pathway Value Creation Strategy Across Pharma, IP and AI-Driven DiscoveryYahoo Finance·Apr 16, 2026
- What's Going On With CDT Equity Shares On Monday?Benzinga·Apr 13, 2026
- CDT Notes Sarborg Publication of PRISM Framework Expanding AIYahoo Finance·Apr 7, 2026
- CDT Equity Expands Tapinarof Intellectual Property Portfolio with Two New Patent FilingsYahoo Finance·Mar 26, 2026
- CDT Equity Inc. Announces Reverse Stock SplitYahoo Finance·Mar 25, 2026
- CDT Identifies Rare Disease Opportunities Through Sarborg Signature Analysis, Advancing Out-Licensing StrategyYahoo Finance·Mar 23, 2026
- CDT Equity Stockholders Approve All Proposals at Special Meeting, Positioning the Company for Next Phase of GrowthYahoo Finance·Mar 18, 2026
- CDT Notes Sarborg Expansion into Rare Disease Signature IntelligenceYahoo Finance·Mar 12, 2026
- CDT Equity Notes Sarborg Filing of U.S. Provisional Patent Application for AI Signature AgentYahoo Finance·Mar 5, 2026
- CDT Positions for Transformational GrowthYahoo Finance·Mar 4, 2026
- CDT Equity Notes Sarborg Expansion into Bacteria and AgrochemicalsYahoo Finance·Feb 24, 2026
- CDT Acquires Strategic Stake in Sarborg to Transform its AI-Driven Asset StrategyYahoo Finance·Feb 20, 2026
- Sector Update: Health Care Stocks Advance Late AfternoonYahoo Finance·Jan 2, 2026
- CDT Equity Identifies New Biological Target Validating AI-Driven Repurposing StrategyYahoo Finance·Aug 26, 2025
- Conduit to Change Name to CDT Equity Inc.Yahoo Finance·Aug 5, 2025
- Conduit Pharmaceuticals Enters Joint Development Agreement with Manoira to Advance AZD1656 and AZD5658 in Animal HealthYahoo Finance·Jun 4, 2025
- Conduit Pharmaceuticals Inc. Listing on Nasdaq Capital MarketYahoo Finance·May 22, 2025
- Conduit Pharmaceuticals Inc. Regains Nasdaq ComplianceYahoo Finance·May 21, 2025
- Conduit Pharmaceuticals Inc. Announces Reverse Stock SplitYahoo Finance·May 16, 2025
All 21 articles loaded
Price Data
52-Week Range
$2.26
Fundamentals
Trading
About CDT Equity Inc
Conduit Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company dedicated to developing cutting-edge therapies for oncology and rare diseases, addressing significant unmet medical needs. Leveraging its proprietary drug delivery platform, Conduit enhances the efficacy and safety profiles of existing treatments, aiming to optimize patient outcomes while minimizing adverse effects. With a highly experienced management team and a focus on strategic partnerships, the company is strategically positioned to advance its innovative product pipeline and contribute meaningfully to the healthcare landscape.